Teva Pharmaceuticals has significant debt levels of over $35 billion at the moment.
http://www.jpost.com/Business-and-Innovation/New-CEO-to-head-struggling-Teva-Pharmaceuticals-504765
They have recently appointed a new CEO Kare Shultz (first non-jew)
They are in the midst of reducing debt to a more manageable level and are taking drastic measures by reducing their workforce by 14% (7,000 people) and selling non core assets.
This is more about Teva than it is about MSB.
Question is who bought their stake?
Cell Therapy News/Articles, page-72
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.030(2.38%) |
Mkt cap ! $1.404B | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.30 | $1.22 | $10.22M | 8.142M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11752 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.23 | 67205 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.23 |
Change
-0.030 ( 3.67 %) |
||||
| Open | High | Low | Volume | ||
| $1.26 | $1.29 | $1.22 | 1670014 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| MSB (ASX) Chart |